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Long-term effects of reduced renal mass in humans. The long-term risks
of kidney donation have not been well defined. We carried out a
meta-analysis of investigations that examined the long-term effects of
reduced renal mass in humans. We used multiple linear regression to
combine studies and adjust for differences in the duration of follow-up, the
reason for reduced renal mass, the type of controls, age and gender. We
analyzed 48 studies with 3124 patients and 1703 controls. Unilateral
nephrectomy caused a decrement in glomerular filtration rate (—17.1
mI/mm; 95% confidence interval —20.2 to 14.0 mi/mm) that tended to
improve with each 10 years of follow-up (1.4 mI/mm/decade; 0.3 to 2.4
mi/mm/decade). Patients with single kidneys had small, progressive in-
creases in proteinuria (76 mg/day/decade; 52 to 101 mg/day/decade), but
proteinuria was negligible after nephrectomy for trauma or kidney dona-
tion. Nephrectomy did not affect the prevalence of hypertension, but there
was a small increase in systolic blood pressure (2.4mm Hg; —0.3 to 5.1 mm
Hg, P > 0.05) which rose further with duration of follow-up (1.1 mm
Hg/decade; 0.0 to 2.2mm Hg/decade). Diastolic blood pressure was higher
after nephrectomy (3.1 mm Hg; 1.8 to 4.4 mm Hg), but this increment did
not change with duration of follow-up. Thus, in normal individuals,
unilateral nephrectomy does not cause progressive renal dysfunction, but
may be associated with a small increase in blood pressure.
A growing shortage of cadaveric organs available for renal
transplantation has been accompanied by an increase in the use of
living donors [1]. It is at least theoretically possible that donating
a kidney for renal transplantation could, after many years, cause
hypertension, proteinuria and renal insufficiency. In rats a surgical
reduction in the number of functioning nephrons leads to hyper-
tension, proteinuria and progressive nephron destruction [2, 31.In
humans, many investigators have failed to find an increased
prevalence of hypertension [4—26], proteinuria [4, 7—9, 12, 17—24,
27—301, or evidence of progressive deterioration in renal function
[4, 5, 7—9, 11—26, 29, 3 1—40]. Others, however, have reported an
increased prevalence of these abnormalities after unilateral ne-
phrectomy [13, 26, 28—34, 41—45], or in patients with unilateral
renal agenesis [46, 47]. Surgical removal of more than 50% of
renal mass (one kidney plus a portion of the other) has been
reported by one group [36], but not by others [35, 38], to cause
progressive renal injury. Differences in the results of these studies
may be due to differences in the amount of renal mass removed,
age at the time of renal mass reduction, unsuspected renal
damage in the remaining kidney, or other factors. In addition, the
relatively small numbers of patients in most studies and the use of
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different controls have made the interpretation of results difficult.
Therefore, we carried out a meta-analysis to examine whether a
reduction in renal mass may lead to progressive changes in
proteinuria, hypertension and/or renal function in humans.
Methods
Study selection
Studies were identified on MEDLINE' using the key word
combination: nephrectomy, kidney, and human. Bibliographies of
pertinent articles were also used. Studies were included if they
reported serum creatinine, creatinine clearance or other measures
of glomerular filtration rate (GFR), urine protein excretion, or
blood pressure after a reduction in renal mass. Studies that did
not attempt to locate all patients from a defined population of
individuals who had a reduction in renal mass were excluded.
Investigations were also excluded if the study population was
biased by selecting patients according to the presence or absence
of hypertension, proteinuria, or other abnormalities. Only studies
with a mean duration of follow-up greater than two years were
included. We did not include abstracts or unpublished data.
Data extracted
Some studies reported individual patient data, some combined
data from all patients, and others reported data for two or more
groups of patients defined by different study or patient character-
istics. Whenever possible, we extracted data from individual cases.
When data from individuals were unavailable, we used groups or
subgroups that provided the greatest amount of descriptive infor-
mation to estimate (see below) data for individuals. In four
studies, data on the same patients were presented more than once,
with tabulations based on different patient characteristics [13, 31,
32, 48]. We extracted all of these data, but weighted the final
analysis proportionately, so that the total number of cases in the
analysis equaled the sum of the patients in the studies. When
results from the same patients were presented at multiple fol-
low-up times, we selected only data from the longest follow-up
that included more than half of the original cohort.
Endpoints included: (1) serum creatinine, (2) GFR estimated
by intravenous markers, or if this was not measured, creatinine
clearance (multiplied by 0.85 to correct for overestimation), or if
neither of these were measured, serum creatinine (using the
Cockcroft and Gault formula [49]); (3) whether or not patients
had protein excretion above a normal range; (4) urine albumin, or
if not measured, total protein excretion; (5) whether or not
patients were hypertensive; (6) systolic blood pressure; and (7)
diastolic blood pressure. In the meta-analysis, hypertension was
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defined as it was defined in each individual study. However,
differences in the level of blood pressure used to define hyperten-
sion were taken into account by including an indicator variable in
the multiple linear regression analysis.
Combining studies
Each case in the analysis was an individual patient. When data
from individual patients were not available, we used a multiple
imputation technique to impute individual values [501. We ran-
domly selected a value from a normal distribution with the same
mean and SD reported for the study group. When a range was also
indicated, we repeated the random selection when needed to
ensure that imputed values fell within the range. For dichotomous
variables such as gender, individuals were randomly assigned so
that the imputed proportion of the group was identical to that
reported. The random assignment of values to individuals using
the descriptive group information provided in the studies was
repeated five times, and the effects of the random imputation
were assessed by comparing the results of analysis based on the
five data sets. Combining both individual data and data from study
groups allowed us to maximize the descriptive information ex-
tracted from each study. Variability within study groups, reflected
by SD5, was preserved as differences between the separate imputed
data sets.
Multiple linear regression
Differences in each endpoint were examined using stepwise
multiple linear regression weighted by inverse variance. A System-
atic approach was used to conserve the number of predictor
variables and thereby limit the possibility that findings were due to
chance. We first examined the effects of major predictor variables
which tested the hypothesis that a reduction in renal mass caused
progressive changes in an endpoint. Major predictor variables
included: 50% reduction in renal mass, more than 50% reduction
in renal mass, age at renal mass reduction, and duration of
follow-up. We also included variables very likely to influence
endpoints: gender, age at the time of study, the level of blood
pressure used to define hypertension, whether GFR was normal-
ized using body surface area, whether urinary albumin or total
protein was measured, and the level of albumin or total protein
excretion used to define the prevalence of proteinuria. For these
major predictor variables we used P < 0.05 as criteria to enter
models.
We next examined whether the reason for the reduction in
renal mass (organ donation, trauma, cancer, infection, nephroli-
thiasis and/or obstructive nephropathy, unilateral agenesis, other
or unknown), and duration of follow-up in each case were
independent predictors. We also examined whether the type of
controls altered the results. For those variables, P < 0.01 was used
to reduce the possibility that findings were the chance result of
examining many variables.
The effect of estimating individual values from group means
and SD5 was investigated by comparing separate predictor vari-
ables made up of actual and estimated values. The analysis was
repeated after randomly selecting individual values for duration,
assuming that the underlying distributions of those values were
exponential rather than normal. An exponential distribution could
occur if proportionately more patients had been followed for
short rather than long durations. Finally, data were re-analyzed
after removing 10 to 20 regression outliers.
A random effects model was used to calculate the inverse
variance regression weight: w1 = 1/(s2 + S2), where w, was the
regression weight for each case from the i-th group. In this
formulation s12 was the within-study variance of the i-th study
group. 2 was the between-study group variance, with S2 = (M —
— 1) — Is2/N,where M was the mean of group means, M =
js1 was the mean for the i-th group, and N was the number
of study groups.
Each regression analysis was repeated five times using the
different data sets generated from the random imputation of
individual values described above. Only predictor variables that
entered models from at least three of the five imputed data sets
were retained. For the final regression models we calculated the
variance for each coefficient that resulted from the imputation
procedure [50]. The final coefficients were the mean of the
regression coefficients from each of the five models. Confidence
intervals were generated by combining within-model and be-
tween-model variance, with the latter reflecting variability due to
imputing missing values. The analysis was carried out using the
Statistical Package for the Social Sciences [51].
Results
Studies and patients
There were 48 studies in the analysis [4—48, 52—54]. Of the 48
studies, 14 were published in 1991 to 1994, 18 in 1986 to 1990, 14
in 1981 to 1985, one in 1974, and one in 1971. Two studies
included patients with unilateral agenesis [46, 47]. Four others
followed patients who had undergone a surgical reduction in renal
mass in childhood [21, 37, 41, 42]. Three investigations included
patients with more than 50% reduction in renal mass [35, 36, 38].
Six measured functional renal reserve capacity [23, 36, 37, 48, 53,
54], but only baseline data from these investigations were included
in this analysis.
There were 2988 patients who had undergone unilateral ne-
phrectomy, 107 who had unilateral agenesis, and 29 who had
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Fig. 1. Duration of follow-up after a reduction in renal mass in 3124
patients. When the duration of follow-up was not known exactly it was
estimated as the mean of five values randomly selected from a distribution
having the same group mean and SD that was reported.
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Table 1. Number of individuals analyzed with individual data values and values imputed from group characteristics
End point or variable Total
Remnant kidney Unilateral nephrectomy Two-kidney controls
Individual Imputed Individual ImputedIndividual Imputed
Serum creatinine 2913 29 0 207 1446 65 1166
Glomerular filtration rate 3381 19 10 88 1845 0 1419
Proteinuria frequency 1679 7 0 1348 0 324 0
Proteinuria 1230 7 0 110 911 61 141
Hypertension frequency 2080 24 0 1532 0 524 0
Systolic blood pressure 1896 14 0 82 1052 50 698
Diastolic blood pressure 1887 14 0 82 1052 50 689
Post-nephrectomy duration 3124 24 5 306 2789 NA NA
Cause of nephrectomy 3124 24 5 2296 799 NA NA
Gender 4827 29 0 674 2421 494 1209
Age of study 4827 15 14 234 2861 65 1638
Shown for each variable are the total number of patients analyzed, the number with actual (individual) values reported by groups, and the number
with individual values imputed for group means, standard deviations and ranges. For proteinuria and hypertension frequencies, all individual values were
assigned 'yes" or "no" based on the group prevalence. Abbreviation is NA, not applicable.
Static effects
Coefficient and 95% confidence
interval mg/dl
Renal mass reduced 50% 0.173 (0.143 to 0.203)
Renal mass reduced >50% 0.962 (0.787 to 1.138)
Age at reduction (each 10 years) 0.031 (0.023 to 0.040)
Male 0.047 (0.021 to 0.073)
Constant (intercept) 0.820 (0.780 to 0.860)
Values are multiple linear regression coefficients and 95% confidence
intervals for independent predictors of serum creatinine. Failure of
confidence intervals to include zero indicate statistical significance. Coef-
ficients are additive. Each coefficient (and confidence interval) is indica-
tive of the independent effect of that variable when the values for the other
variables are held constant. For example, a male undergoing a unilateral
nephrectomy at age 40, would be predicted to have a serum creatinine of
0.820 + 0.173 + 0.124 + 0.047 = 1.16 mg/dl at follow-up.
greater than 50% reduction in renal mass. The reason for the
reduction in renal mass was organ donation in 60.5%, cancer in
10.1%, infection in 8.1%, nephrolithiasis or obstructive uropathy
in 6.8%, unilateral agenesis in 3.4%, trauma in 2.5%, other in
6.8% and unknown in 1.6%. There were 1703 two kidney controls;
69.2% were individuals studied before donation, 12.1% were
potential donors who did not donate, 12.0% were normal individ-
uals from the community, and 6.7% were normal outpatients.
The median duration of follow-up after a reduction in renal
mass was 10.6 years in 3124 patients (Fig. 1). There were 40%
followed more than 13.0 years, 20% more than 21.2 years, and
10% more than 26.4 years. There were 10% followed less than 3.2
years, 20% less than 4.6 years, and 40% less than 7.1 years.
Glomerular filtration rate
Serum creatinine was reported in 2913 individuals (Table 1).
Individuals with a 50% reduction in renal mass had slightly higher
creatinine values compared to controls (Table 2). The 29 individ-
uals with greater than 50% reduction in renal mass had even
higher creatinine levels. Age at the time of renal mass reduction
was also associated with higher serum creatinine. However, there
was a close correlation between age at renal mass reduction and
age at the time of study (r = 0.77), making it difficult to distinguish
with certainty which of these two variables influenced serum
creatinine. Duration after renal mass reduction had no indepen-
dent effect on creatinine, suggesting that there was no progressive
increase.
Static effects
Renal mass reduced 50%
—17.1 (—20.2 to —14.0)
Renal mass reduced >50%
—38.6 (—47.3 to —29.9)
Age at study (each 10 years) —5.3 (—6.0 to —4.7)
Male 6.4 (4.6 to 8.2)
Normalized for B.S.A. 9.3 (7.4 to 11.2)
Constant (intercept) 103.3 (99.5 to 107.1)
Progressive effects (each 10 years)
Renal mass reduced 50% 1.4 (0.3 to 2.5)
Cause: unilateral agenesis 3.8 (1.4 to 6.2)
For 3381 patients (Table 1) GFR could be estimated based on
an isotopic determination in 464 (13.7%), creatinine clearance in
1550 (45.8%), or calculated using the Cockcroft and Gault
relationship in 1367 (40.4%). Renal mass reduction, gender, and
age were associated with decreases in GFR (Table 3). There was
a small progressive increase during the follow-up period for
patients with a 50% reduction in renal mass. This increase was
greater for patients with unilateral agenesis.
Proteinuria
There were 1679 individuals in whom proteinuria was assessed
(Table 1). A 50% reduction in renal mass was associated with an
increased frequency of proteinuria (Table 4). However, there was
a relative decline in the frequency of proteinuria with duration of
follow-up, especially in patients who donated a kidney (Table 4).
In the few patients who had a greater than 50% reduction in mass,
the frequency of proteinuria increased with time. Similarly, pa-
tients with unilateral agenesis had a relative increase in protein-
uria with increasing duration of follow-up.
Similar results were seen when the amount of protein excretion
was analyzed for 1230 patients (Table 1). There was a small
increase in urine protein excretion over time after a 50% reduc-
tion in renal mass (Table 5). However, this increase was not seen
in patients who had reduced renal mass due to trauma or organ
donation.
Table 2. Effect of reduced renal mass on serum creatinine Table 3. Effect of reduced renal mass on glomerular filtration rate.
Coefficient and 95% confidence
interval mi/mm
Values are multiple linear regression coefficients and 95% confidence
intervals for independent predictors of calculated glomerular filtration
rate. A more detailed explanation is provided in the legend to Table 2.
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Table 4. Effect of reduced renal mass on proteinuria frequency
Coefficient and 95% confidence
interval (proportion)
Static effects
Renal mass reduced 50% 0.230 (0.18 1 to 0.278)
Age at study (each 10 years) 0.03 1 (0.17 to 0.045)
Constant (intercept) —0.127 (—0.190 to —0.063)
Progressive effects (each 10 years)
Any renal mass reduction
—0.042 (—0.063 to —0.021)
Renal mass reduced >50% 0.845 (0.423 to 1.266)
Cause: donation
—0.051 (—0.089 to —0.013)
Cause: unilateral agenesis 0.163 (0.128 to 0.197)
Values are multiple linear regression coefficients and 95% confidence
intervals for independent predictors of the frequency of increased urine
protein excretion. The negative value of the constant does not necessarily
indicate a negative proportion (which would be impossible), but a
reduction in the proportion accounted for by other coefficients. A more
detailed explanation is provided in the legend to Table 2.
Table 5. Effect of reduced renal mass on proteinuria
Coefficient and 95% confidence
interval mg/24 hr
Static effects
Male 58 (21 to 94)
Urine albumin measured
—135 (—173 to —98)
Constant (intercept) 85 (55 to 115)
Progressive effects (each 10 years)
Renal mass reduced 50% 76 (52 to 101)
Renal mass reduced >50% 1685 (882 to 2489)
Cause: donation/trauma
—66 (—93 to —39)
Cause: obstruction/stones
—42 (—68 to 17)
Values are multiple linear regression coefficients and 95% confidence
intervals for independent predictors of urine protein excretion. A more
detailed explanation is provided in the legend to Table 2.
Blood pressure
There were 2080 individuals in whom blood pressure was
assessed (Table 1). A 50% reduction in renal mass had no effect
on the prevalence of hypertension (Table 6). In contrast, hyper-
tension was more common and increased with duration of fol-
low-up among the small number of patients with greater than a
50% reduction.
There were 1896 patients with values for systolic blood pressure
(Table 1). A 50% renal mass reduction was associated with a
tendency (P> 0.05) for higher systolic blood pressure, and there
was a small increment in systolic blood pressure with every decade
of follow-up (Table 7). For the small number of patients with
more than 50% reduction in renal mass, there was a much greater
progressive increase in blood pressure.
There were 1887 patients in whom diastolic blood pressure was
reported (Table 1). Patients who had a 50% reduction in renal
mass had slightly higher diastolic blood pressure (Table 8).
However, reduced renal mass was not associated with progressive
increases in diastolic blood pressure during the follow-up period.
Discussion
Whether or not a reduction in renal mass has long-term adverse
consequences has important implications for individuals who wish
to donate a kidney. The results of this meta-analysis suggest that
organ donation does not cause a progressive decline in renal
function or an increased incidence of proteinuria. Unilateral
Table 6. Effect of reduced renal mass on hypertension
Coefficient and 95% confidence
interval (proportion)
Static effects
Age at study (each 10 years) 0.078 (0.067 to 0.089)
Definition >150/90 mm Hg
—0.102 (—0.135 to —0.069)
Constant (intercept) —0.112 (—0.165 to —0.059)
Progressive effects (each 10 years)
Renal mass reduced >50% 0.232 (0.073 to 0.39 1)
Values are multiple linear regression coefficients and 95% confidence
intervals for independent predictors of hypertension. The negative value
of the constant does not necessarily indicate a negative proportion (which
would be impossible), but a reduction in the proportion accounted for by
other coefficients. A more detailed explanation is provided in the legend
to Table 2.
Table 7. Effect of reduced renal mass on systolic blood pressure
Coefficient and 95% confidence
interval mm Hg
Static effects
Renal mass reduced 50% 2.4 (—0.3 to 5.1)
Age at study (each 10 years) 2.0 (1.4 to 2.6)
Male 2.1 (0.1 to 4.0)
Constant (intercept) 116.8 (114.1 to 119.4)
Progressive effects (each 10 years)
Renal mass reduced 50% 1.1 (—0.0 to 2.2)
Renal mass reduced >50% 16.2 (2.6 to 29.8)
Values are multiple linear regression coefficients and 95% confidence
intervals for independent predictors of systolic blood pressor. A more
detailed explanation is provided in the legend to Table 2.
Table 8. Effect of reduced renal mass on diastolic blood pressure
Coefficient and 95% confidence
interval (mm Hg)
Static effects
Renal mass reduced 50% 3.1 (1.8 to 4.4)
Age at study (each 10 years) 0.9 (0.6 to 1.3)
Male 1.1 (—0.3 to 2.5)
Constant (intercept) 74.0 (71.9 to 76.0)
Progressive effects (each 10 years)
Cause: trauma
—1.3 (—2.5 to —0.0)
Values are multiple linear regression coefficients and 95% confidence
intervals for indepedent predictors of diastolic blood pressor. A more
detailed explanation is provided in the legend to Table 2.
nephrectomy may lead to an increase in blood pressure, but this
increment in blood pressure was too small to cause an increased
incidence of hypertension among the large number of patients
studied.
Although reductions in renal mass were associated with in-
creased serum creatinine, these increases were not greater with
longer duration of follow-up, and thus did not appear to be
progressive (Table 2). Serum creatinine can be affected by
changes in muscle mass due to age, gender, and body weight, and
is a relatively inaccurate marker of renal function. Therefore, we
also examined the effects of renal mass on GFR. There was a
decrease in GFR after a 50% reduction in renal mass which was
independent of age, gender, the cause of renal mass reduction,
and duration of follow-up (Table 3). However, the decline in GFR
was not progressive. Indeed, the duration of follow-up was
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associated with a small, progressive increase in GFR, possibly the
result of late, compensatory hypertrophy. The increase in function
was greater in patients with unilateral agenesis, consistent with the
suggestion that compensatory increases in function after a reduc-
tion in renal mass may be age-dependent [551.
Proteinuria may be a marker of renal injury, and proteinuria
was increased in patients with reduced renal mass (Tables 4 and
5). Some increase correlated with duration of follow-up, suggest-
ing that proteinuria was progressive in these patients (Table 5).
However, progressive increases in proteinuria after a reduction in
renal mass may have been due to underlying renal damage.
Indeed, both the amount and prevalence of proteinuria after
kidney donation failed to increase with duration of follow-up.
Thus, there was no evidence that organ donation leads to pro-
gressive renal injury manifested by proteinuria.
There was a small increase in blood pressure after a 50%
reduction in renal mass (Tables 7 and 8), and systolic blood
pressure increased very slightly with longer duration of follow-up.
However, these increases in blood pressure were not enough to
raise the prevalence of hypertension (Table 6), and the clinical
relevance of this finding is unclear. Data from the Framingham
Heart Study would suggest that the 2.4 mm Hg increase in systolic
blood pressure after unilateral nephrectomy would increase the
risk of cardiovascular disease in the following 10 years by 1.9%
[56]. However, the small increase in blood pressure associated
with nephrectomy may not confer the same cardiovascular risk as
a similar increase in blood pressure from other causes in patients
with two kidneys. The true risk of any increase in blood pressure
from reduced renal mass can only be determined in longitudinal
follow-up studies of patients after nephrectomy.
The data we analyzed were cross-sectional. It is possible that
longitudinal follow-up of patients over a long period of time could
reveal additional changes in renal function, blood pressure or
proteinuria that were detected in this meta-analysis. It is also
possible a longer follow-up would demonstrate harmful effects of
reduced renal mass in some patients. However, the relatively large
number of patients who were studied many years after a reduction
in renal mass makes it less likely that any changes in renal
function, proteinuria, or blood pressure not detected in the
present analysis would be clinically relevant. For many older
patients longer follow-up is unlikely. In at least one long-term
follow-up study many of the original cohort had died [7].
It is possible that the data synthesis techniques used in the
present analysis were not sensitive enough, or the studies may not
have included sufficient follow-up to detect subtle changes in renal
function. However, the effects of variables known to influence
renal function, such as age and gender, were evident in the
present analysis. In addition, changes in renal function in only 29
patients with a reduction in renal mass greater than 50% were also
detected. These findings suggest that we were able to detect
clinically relevant changes even when they were small or occurred
in a small number of patients.
Meta-analysis can be influenced by publication bias. Some
studies may not have been published if investigators anticipating
different results failed to submit for publication, or if journals
were less likely to publish the results of negative (or positive)
investigations. Although the epidemiological nature of the present
studies could reduce the chance of publication bias, the results
should, nevertheless, be interpreted with this possibility in mind.
In summary, the results of this meta-analysis suggest that there
is little long-term risk associated with organ donation. Potential
organ donors can be told that the chances of developing end-stage
renal disease as a result of successful organ donation appear to be
extremely remote. Potential donors can also be told that there
may be a small increase in blood pressure after a reduction in
renal mass. However, this increase does not appear to be of
sufficient magnitude to result in a diagnosis of hypertension that
may affect an individual's chances of obtaining insurance. Indeed,
it is unclear whether the small increase in blood pressure after a
reduction in renal mass is of any clinical relevance. Also unclear
is whether this increment in blood pressure should discourage
donation in patients with borderline hypertension. Finally, the
results of the present analysis suggest that remaining questions
will only be answered with large, multicenter studies, or with a
nationally mandated registry of long-term follow-up data from
kidney donors.
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